Fact CheckerSign in

NCT04322890RecruitingPhase 2

Treatment Strategies and Survival Outcome for Non-small Cell Lung Cancer With Oncogenic Mutation

Treatment Strategies and Survival Outcome for Non-small Cell Lung Cancer With Oncogenic Mutation.

Source: ClinicalTrials.gov · Last updated 22 Oct 2024 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

The purpose of this study is to assess the Treatment Strategies and Survival Outcome for Non-small Cell Lung Cancer With Oncogenic Mutation.

Status (registry)
Recruiting
Phase (registry)
Phase 2
Study type
Interventional
Enrollment
6000 (estimated)
First submitted
24 Mar 2020
Start date
16 Apr 2020
Primary completion date
24 Dec 2026
Lead sponsor
Hunan Province Tumor Hospital
Diseases
Lung cancer
NCT number
NCT04322890

What you commit to

  • Study type: Interventional · Phase 2
  • Planned participants: 6000
  • From 16 Apr 2020 to the primary completion date, 24 Dec 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • The patient did not match from the Inclusion Criteria.

Who the study is looking for

  • Understand the requirements and contents of the clinical trial, and provide a signed and dated informed consent form.
  • Age ≥ 18 years.
  • Histologically or cytologically confirmed, Stage IV NSCLC.
  • Oncogenic mutations confirmed by an accredited local laboratory, including EGFR, ALK, ROS1 etc.
  • ECOG 0-1.
  • Predicted survival ≥ 12 weeks.
  • Adequate bone marrow hematopoiesis and organ function
  • Presence of measurable lesions according to RECIST 1.1.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Yongchang Zhang
Coordinator of this site? Confirm its status
ChangshaChinaRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.